StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Glucotrack's free cash flow for the twelve months ending Dec 31, 2025 was -$15.34M. For fiscal 2025 it was -$15.34M. The highest annual figure on record is -$1.17M in fiscal 2009.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.34M–
FY2024Dec 31, 2024-$12.59M–
FY2022Dec 31, 2022-$3.73M–
FY2021Dec 31, 2021-$3.77M–
FY2020Dec 31, 2020-$3.55M–
FY2019Dec 31, 2019-$3.92M–
FY2018Dec 31, 2018-$4.90M–
FY2017Dec 31, 2017-$5.91M–
FY2016Dec 31, 2016-$5.39M–
FY2015Dec 31, 2015-$4.71M–
FY2014Dec 31, 2014-$3.43M–
FY2013Dec 31, 2013-$3.28M–
FY2012Dec 31, 2012-$2.31M–
FY2011Dec 31, 2011-$1.97M–
FY2010Dec 31, 2010-$1.38M–
FY2009Dec 31, 2009-$1.17M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$3.96M–
Q3 FY2025Sep 30, 2025-$4.69M–
Q2 FY2025Jun 30, 2025-$3.74M–
Q1 FY2025Mar 31, 2025-$2.95M–
Q4 FY2024Dec 31, 2024-$3.50M–
Q3 FY2024Sep 30, 2024-$4.18M–
Q2 FY2024Jun 30, 2024-$1.92M–
Q1 FY2024Mar 31, 2024-$3.00M–
Q4 FY2022Dec 31, 2022-$937.00K–
Q3 FY2022Sep 30, 2022-$608.00K–
Q4 FY2021Dec 31, 2021-$977.00K–
Q3 FY2021Sep 30, 2021-$894.00K–
Q4 FY2020Dec 31, 2020-$851.00K–
Q3 FY2020Sep 30, 2020-$796.00K–
Q2 FY2020Jun 30, 2020-$903.00K–
Q1 FY2020Mar 31, 2020-$1.00M–
Q4 FY2019Dec 31, 2019-$796.94K–
Q3 FY2019Sep 30, 2019-$1.07M–
Q2 FY2019Jun 30, 2019-$1.22M–
Q1 FY2019Mar 31, 2019-$827.40K–
Q4 FY2018Dec 31, 2018-$1.09M–
Q3 FY2018Sep 30, 2018-$1.36M–
Q2 FY2018Jun 30, 2018-$1.02M–
Q1 FY2018Mar 31, 2018-$1.43M–
Q4 FY2017Dec 31, 2017-$788.01K–
Q3 FY2017Sep 30, 2017-$1.52M–
Q2 FY2017Jun 30, 2017-$2.46M–
Q1 FY2017Mar 31, 2017-$1.15M–
Q4 FY2016Dec 31, 2016-$966.73K–
Q3 FY2016Sep 30, 2016-$1.49M–

More Glucotrack figures

See a number that looks wrong?